Profil Financier
Leopoldo Espinosa Abdalá occupe actuellement le rang #2563 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.6 B ($0 sur 24h).
Leopoldo Espinosa Abdalá and his brother Fernando gets the bulk of their wealth from the 2016 sale of their drug manufacturer Rimsa, which it sold to Tel Aviv-based Teva Pharmaceuticals for $2.3 billion.
Leopoldo was the executive president of the privately-held Mexican company before the sale.
Their father founded the business in 1970 as a pharmaceutical distributor before expanding into manufacturing.
At the time of the sale Risma was known for a slew of patented products, most notably its fixed-dose drug combinations.
Following the sale, Teva sued Leopoldo and Fernando claiming fraud and a breach of contract. The charges were mostly dismissed; the parties eventually settled for less than $200 million.